Handelsbanken Fonder AB - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 164 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$660
-20.6%
13,1510.0%0.00%0.0%
Q2 2023$831
+24.4%
13,151
-11.4%
0.00%0.0%
Q1 2023$668
+48.8%
14,851
+44.9%
0.00%
+33.3%
Q4 2022$449
-99.9%
10,251
+7.3%
0.00%
-25.0%
Q3 2022$629,000
+30.5%
9,5510.0%0.00%
+33.3%
Q2 2022$482,000
-21.0%
9,5510.0%0.00%0.0%
Q1 2022$610,000
-40.4%
9,5510.0%0.00%
-40.0%
Q4 2021$1,023,000
-17.4%
9,551
-20.7%
0.01%
-16.7%
Q3 2021$1,239,000
+16.9%
12,0510.0%0.01%0.0%
Q2 2021$1,060,000
+20.5%
12,051
+33.1%
0.01%
+20.0%
Q1 2021$880,000
-13.3%
9,0510.0%0.01%
-16.7%
Q4 2020$1,015,000
+21.0%
9,0510.0%0.01%0.0%
Q3 2020$839,000
-40.6%
9,051
-50.0%
0.01%0.0%
Q2 2020$1,412,000
-52.4%
18,102
-52.4%
0.01%
-83.3%
Q3 2018$2,966,000
+145.9%
38,000
+100.0%
0.04%
+50.0%
Q2 2018$1,206,00019,0000.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders